Anne T Reutens

Summary

Country: Australia

Publications

  1. doi request reprint The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice
    Anne T Reutens
    Baker IDI Heart and Diabetes Institute, Melbourne, Australia
    Diabetes Res Clin Pract 98:38-45. 2012
  2. doi request reprint Epidemiology of diabetic kidney disease
    Anne T Reutens
    Department of Epidemiology and Preventive Medicine, Alfred Centre, Monash University, Melbourne, Victoria 3004, Australia
    Med Clin North Am 97:1-18. 2013
  3. doi request reprint Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers
    Sara E Ivory
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Nephrology (Carlton) 18:516-24. 2013
  4. doi request reprint Epidemiology of diabetic nephropathy
    Anne T Reutens
    School of Public Health and Preventive Medicine, Monash University, and Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia
    Contrib Nephrol 170:1-7. 2011
  5. pmc Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy
    David K Packham
    Melbourne Renal Research Group, 73 75 Pine Street, Reservoir, Melbourne, Victoria 3073, Australia
    J Am Soc Nephrol 23:123-30. 2012

Collaborators

Detail Information

Publications5

  1. doi request reprint The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice
    Anne T Reutens
    Baker IDI Heart and Diabetes Institute, Melbourne, Australia
    Diabetes Res Clin Pract 98:38-45. 2012
    ..Primary aim: does general practitioner (GP) education on type 2 diabetes treatment improve HbA1c? Secondary aim: cardiovascular risk factors, hypoglycaemia, treatment intensification, health service utilisation, treatment barriers...
  2. doi request reprint Epidemiology of diabetic kidney disease
    Anne T Reutens
    Department of Epidemiology and Preventive Medicine, Alfred Centre, Monash University, Melbourne, Victoria 3004, Australia
    Med Clin North Am 97:1-18. 2013
    ..There is emerging evidence that changes in renal function occurring early in the course of diabetes predict future outcomes. The major challenges are to prevent DKD onset, to detect it early, and to improve DKD outcomes globally...
  3. doi request reprint Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers
    Sara E Ivory
    Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Nephrology (Carlton) 18:516-24. 2013
    ....
  4. doi request reprint Epidemiology of diabetic nephropathy
    Anne T Reutens
    School of Public Health and Preventive Medicine, Monash University, and Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia
    Contrib Nephrol 170:1-7. 2011
    ..This will produce significant social and economic ramifications, particularly in the developing world...
  5. pmc Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy
    David K Packham
    Melbourne Renal Research Group, 73 75 Pine Street, Reservoir, Melbourne, Victoria 3073, Australia
    J Am Soc Nephrol 23:123-30. 2012
    ..Side effect profiles were similar for both groups. In conclusion, these data do not suggest a renoprotective benefit of sulodexide in patients with type 2 diabetes, renal impairment, and macroalbuminuria...